======= HEXIM1 ======= == Gene Information == * **Official Symbol**: HEXIM1 * **Official Name**: HEXIM P-TEFb complex subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10614|10614]] * **UniProt**: [[https://www.uniprot.org/uniprot/O94992|O94992]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HEXIM1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HEXIM1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607328|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor (PubMed:14580347, PubMed:15713661, PubMed:15201869). In cooperation with 7SK snRNA sequesters P-TEFb in a large inactive 7SK snRNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (PubMed:12832472, PubMed:14580347, PubMed:15713661, PubMed:15201869). May also regulate NF-kappa-B, ESR1, NR3C1 and CIITA-dependent transcriptional activity (PubMed:15940264, PubMed:15941832, PubMed:17088550). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). {ECO:0000269|PubMed:12581153, ECO:0000269|PubMed:12832472, ECO:0000269|PubMed:14580347, ECO:0000269|PubMed:15201869, ECO:0000269|PubMed:15713661, ECO:0000269|PubMed:15940264, ECO:0000269|PubMed:15941832, ECO:0000269|PubMed:17088550, ECO:0000269|PubMed:28712728}. No Pfam Domain information is available for this gene. |snRNA binding| |7SK snRNA binding| |cyclin-dependent protein serine/threonine kinase inhibitor activity| |positive regulation of signal transduction by p53 class mediator| |negative regulation of cyclin-dependent protein serine/threonine kinase activity| |negative regulation of cyclin-dependent protein kinase activity| |regulation of cyclin-dependent protein serine/threonine kinase activity| |regulation of cyclin-dependent protein kinase activity| |negative regulation of protein serine/threonine kinase activity| |regulation of signal transduction by p53 class mediator| |negative regulation of protein kinase activity| |negative regulation of kinase activity| |activation of innate immune response| |negative regulation of transferase activity| |positive regulation of innate immune response| |positive regulation of response to biotic stimulus| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |regulation of innate immune response| |positive regulation of defense response| |positive regulation of multi-organism process| |regulation of protein serine/threonine kinase activity| |regulation of response to biotic stimulus| |heart development| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of cell cycle| |negative regulation of protein modification process| |positive regulation of response to external stimulus| |activation of immune response| |regulation of defense response| |innate immune response| |regulation of multi-organism process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |negative regulation of transcription by RNA polymerase II| |positive regulation of immune response| |circulatory system development| |regulation of kinase activity| |defense response to other organism| |regulation of transferase activity| |positive regulation of intracellular signal transduction| |negative regulation of cellular protein metabolic process| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of immune response| |positive regulation of immune system process| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |negative regulation of RNA metabolic process| |defense response| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |regulation of phosphorylation| |positive regulation of signal transduction| |regulation of immune system process| |negative regulation of gene expression| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-3.27| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-2.86| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-2.85| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.58| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-2.52| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-2.52| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-2.51| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-2.51| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.48| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-2.39| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-2.34| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.34| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|-2.31| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-2.31| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|-2.28| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-2.21| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-2.17| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-2.14| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.13| |[[:results:exp70|INK128 0.2μM R02 exp70]]|-1.97| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.95| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.95| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-1.92| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.87| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.86| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.83| |[[:results:exp532|TIC10 10μM R08 exp532]]|-1.81| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|-1.78| |[[:results:exp360|Genistein 15μM R07 exp360]]|-1.75| |[[:results:exp211|AICAR 240μM R05 exp211]]|-1.74| |[[:results:exp515|PU-H71 1μM R08 exp515]]|-1.7| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|1.74| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|1.77| |[[:results:exp187|proTAME 5μM R04 exp187]]|1.81| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.84| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.88| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.92| |[[:results:exp453|B02 10μM R08 exp453]]|2| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|2.14| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|2.18| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.54| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|2.65| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|2.65| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|2.76| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|2.93| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|3.01| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|3.77| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|3.8| ^Gene^Correlation^ |[[:human genes:l:larp7|LARP7]]|0.633| |[[:human genes:r:rbm26|RBM26]]|0.481| |[[:human genes:p:prim1|PRIM1]]|0.445| |[[:human genes:i:ing1|ING1]]|0.442| |[[:human genes:m:mepce|MEPCE]]|0.437| |[[:human genes:s:szt2|SZT2]]|0.426| |[[:human genes:b:brms1|BRMS1]]|0.422| |[[:human genes:n:nprl3|NPRL3]]|0.402| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|1/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17768 * **Expression level (log2 read counts)**: 4.93 {{:chemogenomics:nalm6 dist.png?nolink |}}